Tuesday, June 16, 2026

Medipost’s CARTISTEM® Completes Phase 3 Trials in Japan: What This Means for Knee Osteoarthritis Treatment

Medipost completes Phase 3 trial for CARTISTEM in Japan, targeting knee osteoarthritis treatment and planning U.S. trial enrollment soon.

Unlocking Secrets of North Korea: A Language and Culture Forum You Can’t Miss

South Korea’s 2nd Inter-Korean Cultural Exchange Forum on September 10 will explore North-South Korean language and cultural differences.

Kim Jong Un Emphasizes Artillery Power: Key Takeaways from North Korea’s Military Drill on April 15

Kim Jong Un emphasized artillery strength during a competition, marking the Day of the Sun, highlighting military readiness and modernization.

Tag: Investor

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

How Daewoong, Naver, and J&P Medi are Transforming Digital Health: Key Insights from the 2026 Partners Day

The event showcases 10 startups presenting innovations in digital healthcare, focusing on AI, brain health, and business strategies.

Celltrion Gets Global IB Upgrades: Morgan Stanley Raises Target to $206.25 as New Biosimilars Lift Margins

Celltrion is expanding through biosimilars and new drug development, attracting global investor interest and raising target stock prices.

SK Hynix Soars 4% After K-Chips Act Boosts Investor Sentiment

SK Hynix shares rose nearly 4% after the “K-Chips Act” passed, boosting semiconductor tax credits and investor sentiment.

Tech Turmoil: Dow, S&P, and Nasdaq Slip Ahead of Microsoft and Meta Reports

U.S. stock markets fell across the board ahead of Big Tech earnings reports released after the closing bell.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.